Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	STAB2 LRP1B LDLR LRP2	2.36e-06	16	123	4	GO:0005041
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-7 ERVK-21 ERVK-9 ERVK-18 ERVK-24	3.04e-06	37	123	5	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-7 ERVK-21 ERVK-9 ERVK-18 ERVK-24	3.49e-06	38	123	5	GO:0070001
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	STAB2 LRP1B LDLR LRP2	7.57e-06	21	123	4	GO:0030228
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor	GLUD1 GLUD2	3.76e-05	2	123	2	GO:0016639
GeneOntologyMolecularFunction	hydroxymethylglutaryl-CoA lyase activity	HMGCL HMGCLL1	3.76e-05	2	123	2	GO:0004419
GeneOntologyMolecularFunction	glutamate dehydrogenase [NAD(P)+] activity	GLUD1 GLUD2	3.76e-05	2	123	2	GO:0004353
GeneOntologyMolecularFunction	glutamate dehydrogenase (NAD+) activity	GLUD1 GLUD2	3.76e-05	2	123	2	GO:0004352
GeneOntologyMolecularFunction	glutamate dehydrogenase (NADP+) activity	GLUD1 GLUD2	3.76e-05	2	123	2	GO:0004354
GeneOntologyMolecularFunction	calcium ion binding	STAB2 MATN2 MATN3 ZZEF1 TBC1D8B LRP1B LDLR FAT2 HMCN2 NKD1 MEGF8 LRP2 PLCH1 RASGRP2	2.13e-04	749	123	14	GO:0005509
GeneOntologyMolecularFunction	endopeptidase activity	ERVK-7 ERVK-21 ERVK-9 TPSD1 CLCA1 LPA ERVK-18 SENP6 ERVK-24 PSMD14	3.33e-04	430	123	10	GO:0004175
GeneOntologyMolecularFunction	neurotrophin receptor activity	NTRK2 SORT1	3.72e-04	5	123	2	GO:0005030
GeneOntologyMolecularFunction	L-leucine binding	GLUD1 GLUD2	7.75e-04	7	123	2	GO:0070728
GeneOntologyMolecularFunction	oxo-acid-lyase activity	HMGCL HMGCLL1	7.75e-04	7	123	2	GO:0016833
GeneOntologyMolecularFunction	structural molecule activity	VWF MATN2 MATN3 LAMB2 HMGCL ERVK-7 ERVK-21 ERVK-9 NEB HMCN2 ERVK-18 PLEC ERVK-24 OTOG	1.18e-03	891	123	14	GO:0005198
GeneOntologyMolecularFunction	retromer complex binding	TBC1D5 SORT1	1.64e-03	10	123	2	GO:1905394
GeneOntologyMolecularFunction	cargo receptor activity	STAB2 LRP1B LDLR LRP2	1.89e-03	85	123	4	GO:0038024
GeneOntologyCellularComponent	matrilin complex	MATN2 MATN3	2.11e-04	4	125	2	GO:0120216
GeneOntologyCellularComponent	external side of plasma membrane	STAB2 VWF NRCAM L1CAM LAG3 MR1 LDLR CD1C CD163L1 LPA LRP2	2.88e-04	519	125	11	GO:0009897
Domain	EGF-like_dom	CNTNAP3B STAB2 MATN2 MATN3 CNTNAP3 LAMB2 LRP1B LDLR FAT2 HMCN2 MEGF8 LRP2 OTOG	5.57e-09	249	117	13	IPR000742
Domain	EGF_3	CNTNAP3B STAB2 MATN2 MATN3 CNTNAP3 LRP1B LDLR FAT2 HMCN2 MEGF8 LRP2 OTOG	2.84e-08	235	117	12	PS50026
Domain	EGF_CA	STAB2 MATN2 MATN3 LRP1B LDLR FAT2 HMCN2 MEGF8 LRP2	7.34e-08	122	117	9	SM00179
Domain	EGF-like_Ca-bd_dom	STAB2 MATN2 MATN3 LRP1B LDLR FAT2 HMCN2 MEGF8 LRP2	8.45e-08	124	117	9	IPR001881
Domain	EGF_2	CNTNAP3B STAB2 MATN2 MATN3 CNTNAP3 LAMB2 LRP1B LDLR FAT2 HMCN2 MEGF8 LRP2	1.06e-07	265	117	12	PS01186
Domain	EGF	CNTNAP3B STAB2 MATN2 MATN3 CNTNAP3 LAMB2 LRP1B LDLR FAT2 MEGF8 LRP2	2.66e-07	235	117	11	SM00181
Domain	Growth_fac_rcpt_	STAB2 MATN2 MATN3 LAMB2 LRP1B LDLR HMCN2 MEGF8 LRP2	6.01e-07	156	117	9	IPR009030
Domain	EGF-like_CS	STAB2 MATN2 MATN3 CNTNAP3 LAMB2 LRP1B LDLR FAT2 HMCN2 MEGF8 LRP2	7.55e-07	261	117	11	IPR013032
Domain	EGF_CA	MATN2 MATN3 LRP1B LDLR HMCN2 MEGF8 LRP2	1.13e-06	86	117	7	PF07645
Domain	TIL_dom	VWF MUC5B LRP2 OTOG	1.39e-06	14	117	4	IPR002919
Domain	EGF_1	CNTNAP3B STAB2 CNTNAP3 LAMB2 LRP1B LDLR FAT2 HMCN2 MEGF8 LRP2	4.68e-06	255	117	10	PS00022
Domain	EGF	STAB2 MATN2 MATN3 CNTNAP3 LRP1B FAT2 LRP2	1.44e-05	126	117	7	PF00008
Domain	ELFV_dehydrog_N	GLUD1 GLUD2	3.89e-05	2	117	2	PF02812
Domain	Glu/Leu/Phe/Val_DH_C	GLUD1 GLUD2	3.89e-05	2	117	2	IPR006096
Domain	Glu/Leu/Phe/Val_DH_dimer_dom	GLUD1 GLUD2	3.89e-05	2	117	2	IPR006097
Domain	Glu/Leu/Phe/Val_DH	GLUD1 GLUD2	3.89e-05	2	117	2	IPR006095
Domain	ELFV_dehydrog	GLUD1 GLUD2	3.89e-05	2	117	2	PF00208
Domain	ELFV_dehydrog	GLUD1 GLUD2	3.89e-05	2	117	2	SM00839
Domain	Glu/Leu/Phe/Val_DH_AS	GLUD1 GLUD2	3.89e-05	2	117	2	IPR033524
Domain	HMG_COA_LYASE	HMGCL HMGCLL1	3.89e-05	2	117	2	PS01062
Domain	NAD_bind_Glu_DH	GLUD1 GLUD2	3.89e-05	2	117	2	IPR033922
Domain	GLFV_DEHYDROGENASE	GLUD1 GLUD2	3.89e-05	2	117	2	PS00074
Domain	ASX_HYDROXYL	MATN2 LRP1B LDLR HMCN2 MEGF8 LRP2	3.92e-05	100	117	6	PS00010
Domain	TIL	VWF MUC5B OTOG	5.06e-05	12	117	3	PF01826
Domain	C8	VWF MUC5B OTOG	5.06e-05	12	117	3	PF08742
Domain	EGF-type_Asp/Asn_hydroxyl_site	MATN2 LRP1B LDLR HMCN2 MEGF8 LRP2	5.44e-05	106	117	6	IPR000152
Domain	IG_LIKE	FLT4 NRCAM SPEG NTRK2 L1CAM LAG3 MR1 PTPRU CD1C CSF1R HMCN2 NECTIN4	5.99e-05	491	117	12	PS50835
Domain	Unchr_dom_Cys-rich	VWF MUC5B OTOG	6.55e-05	13	117	3	IPR014853
Domain	C8	VWF MUC5B OTOG	6.55e-05	13	117	3	SM00832
Domain	Ig-like_dom	FLT4 NRCAM SPEG NTRK2 L1CAM LAG3 MR1 PTPRU CD1C CSF1R HMCN2 NECTIN4	7.54e-05	503	117	12	IPR007110
Domain	Ldl_recept_b	LRP1B LDLR LRP2	8.29e-05	14	117	3	PF00058
Domain	LDLRB	LRP1B LDLR LRP2	8.29e-05	14	117	3	PS51120
Domain	LY	LRP1B LDLR LRP2	1.03e-04	15	117	3	SM00135
Domain	LDLR_classB_rpt	LRP1B LDLR LRP2	1.03e-04	15	117	3	IPR000033
Domain	PYR_CT	HMGCL HMGCLL1	1.16e-04	3	117	2	IPR000891
Domain	HMGL-like	HMGCL HMGCLL1	1.16e-04	3	117	2	PF00682
Domain	PYR_CT	HMGCL HMGCLL1	1.16e-04	3	117	2	PS50991
Domain	IGc2	FLT4 NRCAM SPEG NTRK2 L1CAM CSF1R HMCN2 NECTIN4	1.17e-04	235	117	8	SM00408
Domain	Ig_sub2	FLT4 NRCAM SPEG NTRK2 L1CAM CSF1R HMCN2 NECTIN4	1.17e-04	235	117	8	IPR003598
Domain	VWD	VWF MUC5B OTOG	1.26e-04	16	117	3	SM00216
Domain	VWF_type-D	VWF MUC5B OTOG	1.26e-04	16	117	3	IPR001846
Domain	VWFD	VWF MUC5B OTOG	1.26e-04	16	117	3	PS51233
Domain	VWD	VWF MUC5B OTOG	1.26e-04	16	117	3	PF00094
Domain	VWFA	VWF MATN2 MATN3 CLCA1 HMCN2	1.64e-04	82	117	5	PS50234
Domain	VWA	VWF MATN2 MATN3 CLCA1 HMCN2	1.84e-04	84	117	5	SM00327
Domain	VWC_out	VWF MUC5B OTOG	2.16e-04	19	117	3	SM00215
Domain	-	MATN2 MATN3	2.32e-04	4	117	2	1.20.5.30
Domain	Neurofascin/L1/NrCAM_C	NRCAM L1CAM	2.32e-04	4	117	2	IPR026966
Domain	Matrilin_ccoil	MATN2 MATN3	2.32e-04	4	117	2	PF10393
Domain	Bravo_FIGEY	NRCAM L1CAM	2.32e-04	4	117	2	PF13882
Domain	Matrilin_coiled-coil_trimer	MATN2 MATN3	2.32e-04	4	117	2	IPR019466
Domain	Matrilin_ccoil	MATN2 MATN3	2.32e-04	4	117	2	SM01279
Domain	Galactose-bd-like	CNTNAP3B CNTNAP3 LAMB2 PTPRU ZZEF1	3.12e-04	94	117	5	IPR008979
Domain	IG	FLT4 NRCAM SPEG NTRK2 L1CAM LAG3 PTPRU CSF1R HMCN2 NECTIN4	3.18e-04	421	117	10	SM00409
Domain	Ig_sub	FLT4 NRCAM SPEG NTRK2 L1CAM LAG3 PTPRU CSF1R HMCN2 NECTIN4	3.18e-04	421	117	10	IPR003599
Domain	CT	VWF MUC5B OTOG	3.38e-04	22	117	3	SM00041
Domain	EGF_Ca-bd_CS	LRP1B LDLR HMCN2 MEGF8 LRP2	3.61e-04	97	117	5	IPR018097
Domain	EGF_CA	LRP1B LDLR HMCN2 MEGF8 LRP2	3.96e-04	99	117	5	PS01187
Domain	VWF_A	VWF MATN2 MATN3 CLCA1 HMCN2	3.96e-04	99	117	5	IPR002035
Domain	VWA	VWF MATN2 MATN3 CLCA1	4.18e-04	56	117	4	PF00092
Domain	Ig-like_fold	FLT4 NRCAM SPEG NTRK2 L1CAM LAG3 MR1 PTPRU IFNGR1 CD1C CSF1R HMCN2 NECTIN4	4.80e-04	706	117	13	IPR013783
Domain	Cys_knot_C	VWF MUC5B OTOG	4.98e-04	25	117	3	IPR006207
Domain	CTCK_2	VWF MUC5B OTOG	4.98e-04	25	117	3	PS01225
Domain	cEGF	MATN2 LRP1B LRP2	5.61e-04	26	117	3	IPR026823
Domain	cEGF	MATN2 LRP1B LRP2	5.61e-04	26	117	3	PF12662
Domain	PRELI_MSF1	SEC14L5 SEC14L1	5.74e-04	6	117	2	PS50904
Domain	PRELI	SEC14L5 SEC14L1	5.74e-04	6	117	2	PF04707
Domain	CP2	TFCP2 TFCP2L1	5.74e-04	6	117	2	PF04516
Domain	PRELI/MSF1_dom	SEC14L5 SEC14L1	5.74e-04	6	117	2	IPR006797
Domain	CP2	TFCP2 TFCP2L1	5.74e-04	6	117	2	IPR007604
Domain	EGF_LAM_2	STAB2 LAMB2 MEGF8	8.60e-04	30	117	3	PS50027
Domain	EGF_LAM_1	STAB2 LAMB2 MEGF8	8.60e-04	30	117	3	PS01248
Domain	-	FLT4 NRCAM SPEG NTRK2 L1CAM LAG3 MR1 PTPRU IFNGR1 CD1C CSF1R NECTIN4	9.27e-04	663	117	12	2.60.40.10
Domain	Tyr_kinase_rcpt_3_CS	FLT4 CSF1R	1.06e-03	8	117	2	IPR001824
Domain	RECEPTOR_TYR_KIN_III	FLT4 CSF1R	1.06e-03	8	117	2	PS00240
Domain	-	VWF MATN2 MATN3 CLCA1	1.20e-03	74	117	4	3.40.50.410
Domain	Ig_I-set	FLT4 NRCAM SPEG NTRK2 L1CAM HMCN2	1.26e-03	190	117	6	IPR013098
Domain	I-set	FLT4 NRCAM SPEG NTRK2 L1CAM HMCN2	1.26e-03	190	117	6	PF07679
Domain	EGF_Lam	STAB2 LAMB2 MEGF8	1.35e-03	35	117	3	SM00180
Domain	LAM_G_DOMAIN	CNTNAP3B CNTNAP3 FAT2	1.72e-03	38	117	3	PS50025
Domain	Laminin_EGF	STAB2 LAMB2 MEGF8	1.72e-03	38	117	3	IPR002049
Domain	-	LRP1B LDLR LRP2	1.86e-03	39	117	3	2.120.10.30
Domain	LDLR_class-A_CS	LRP1B LDLR LRP2	2.00e-03	40	117	3	IPR023415
Domain	Laminin_G_2	CNTNAP3B CNTNAP3 FAT2	2.00e-03	40	117	3	PF02210
Domain	CRAL_TRIO_N	SEC14L5 SEC14L1	2.06e-03	11	117	2	PF03765
Domain	VWF_dom	VWF MUC5B OTOG	2.30e-03	42	117	3	IPR001007
Domain	EGF_3	STAB2 MEGF8	2.46e-03	12	117	2	PF12947
Domain	EGF_dom	STAB2 MEGF8	2.46e-03	12	117	2	IPR024731
Domain	CRAL-bd_toc_tran	SEC14L5 SEC14L1	2.46e-03	12	117	2	IPR001071
Domain	CRAL_TRIO_N	SEC14L5 SEC14L1	2.46e-03	12	117	2	SM01100
Domain	LamG	CNTNAP3B CNTNAP3 FAT2	2.63e-03	44	117	3	SM00282
Domain	Ldl_recept_a	LRP1B LDLR LRP2	2.81e-03	45	117	3	PF00057
Domain	-	LRP1B LDLR LRP2	2.99e-03	46	117	3	4.10.400.10
Domain	6-blade_b-propeller_TolB-like	LRP1B LDLR LRP2	2.99e-03	46	117	3	IPR011042
Domain	LDLRA_1	LRP1B LDLR LRP2	3.38e-03	48	117	3	PS01209
Domain	LDLRA_2	LRP1B LDLR LRP2	3.58e-03	49	117	3	PS50068
Domain	LDrepeatLR_classA_rpt	LRP1B LDLR LRP2	3.58e-03	49	117	3	IPR002172
Domain	LDLa	LRP1B LDLR LRP2	3.58e-03	49	117	3	SM00192
Domain	TBC	SGSM1 TBC1D5 TBC1D8B	3.58e-03	49	117	3	SM00164
Domain	CRAL/TRIO_N_dom	SEC14L5 SEC14L1	3.87e-03	15	117	2	IPR011074
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-7 ERVK-21 ERVK-18	4.62e-07	5	126	3	12629516
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-21 ERVK-9 ERVK-18 ERVK-24	4.83e-07	18	126	4	18664271
Pubmed	The extracellular-matrix protein matrilin 2 participates in peripheral nerve regeneration.	MATN2 MATN3 LAMB2	3.84e-06	9	126	3	19295126
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	FLT4 NRCAM NTRK2 L1CAM LDLR FAT2 CSF1R MEGF8	4.72e-06	257	126	8	16335952
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ENTPD7 TRAF7 NR2C2 MATN2 L1CAM CNTNAP3 MR1 LAMB2 ZZEF1 LRP1B NCAPG2 LDLR TSPAN3 SORT1 IFNGR1 MEGF8	7.49e-06	1201	126	16	35696571
Pubmed	Glutamate Delta-1 Receptor Regulates Inhibitory Neurotransmission in the Nucleus Accumbens Core and Anxiety-Like Behaviors.	GLUD1 GLUD2	1.30e-05	2	126	2	34173171
Pubmed	Glutamate dehydrogenase is essential to sustain neuronal oxidative energy metabolism during stimulation.	GLUD1 GLUD2	1.30e-05	2	126	2	28621566
Pubmed	GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior.	GLUD1 GLUD2	1.30e-05	2	126	2	32078638
Pubmed	Development of mice with brain-specific deletion of floxed glud1 (glutamate dehydrogenase 1) using cre recombinase driven by the nestin promoter.	GLUD1 GLUD2	1.30e-05	2	126	2	23595828
Pubmed	Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson's Disease.	APAF1 CSF1R	1.30e-05	2	126	2	37108258
Pubmed	Sortilin mediates vascular calcification via its recruitment into extracellular vesicles.	LDLR SORT1	1.30e-05	2	126	2	26950419
Pubmed	Interaction between glutamate dehydrogenase (GDH) and L-leucine catabolic enzymes: intersecting metabolic pathways.	GLUD1 GLUD2	1.30e-05	2	126	2	21621574
Pubmed	Characterization of a novel HMG-CoA lyase enzyme with a dual location in endoplasmic reticulum and cytosol.	HMGCL HMGCLL1	1.30e-05	2	126	2	22847177
Pubmed	Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.	GLUD1 GLUD2	1.30e-05	2	126	2	28911206
Pubmed	Delineation of glutamate pathways and secretory responses in pancreatic islets with β-cell-specific abrogation of the glutamate dehydrogenase.	GLUD1 GLUD2	1.30e-05	2	126	2	22875990
Pubmed	Molecular basis of human glutamate dehydrogenase regulation under changing energy demands.	GLUD1 GLUD2	1.30e-05	2	126	2	15578726
Pubmed	Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes.	GLUD1 GLUD2	1.30e-05	2	126	2	15044002
Pubmed	Induction of excitatory and inhibitory presynaptic differentiation by GluD1.	GLUD1 GLUD2	1.30e-05	2	126	2	22138648
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3B CNTNAP3	1.30e-05	2	126	2	26807827
Pubmed	Glutamate Dehydrogenase Is Important for Ammonia Fixation and Amino Acid Homeostasis in Brain During Hyperammonemia.	GLUD1 GLUD2	1.30e-05	2	126	2	34220417
Pubmed	Transcriptional control of intestinal cholesterol absorption, adipose energy expenditure and lipid handling by Sortilin.	LDLR SORT1	1.30e-05	2	126	2	29899496
Pubmed	Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues.	GLUD1 GLUD2	1.30e-05	2	126	2	26241911
Pubmed	Differential levels of glutamate dehydrogenase 1 (GLUD1) in Balb/c and C57BL/6 mice and the effects of overexpression of the Glud1 gene on glutamate release in striatum.	GLUD1 GLUD2	1.30e-05	2	126	2	21446915
Pubmed	3-Hydroxy-3-methylglutaryl coenzyme A lyase (HL). Cloning of human and chicken liver HL cDNAs and characterization of a mutation causing human HL deficiency.	HMGCL HMGCLL1	1.30e-05	2	126	2	8440722
Pubmed	GluD1 binds GABA and controls inhibitory plasticity.	GLUD1 GLUD2	1.30e-05	2	126	2	38060673
Pubmed	Modulation of CP2 family transcriptional activity by CRTR-1 and sumoylation.	TFCP2 TFCP2L1	1.30e-05	2	126	2	20661472
Pubmed	Gene expression patterns in the hippocampus during the development and aging of Glud1 (Glutamate Dehydrogenase 1) transgenic and wild type mice.	GLUD1 GLUD2	1.30e-05	2	126	2	24593767
Pubmed	Potentiation of neuronal activity by tonic GluD1 current in brain slices.	GLUD1 GLUD2	1.30e-05	2	126	2	37154294
Pubmed	Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export.	LDLR SORT1	1.30e-05	2	126	2	20816088
Pubmed	Deletion of glutamate dehydrogenase 1 (Glud1) in the central nervous system affects glutamate handling without altering synaptic transmission.	GLUD1 GLUD2	1.30e-05	2	126	2	22924626
Pubmed	Nerve tissue-specific (GLUD2) and housekeeping (GLUD1) human glutamate dehydrogenases are regulated by distinct allosteric mechanisms: implications for biologic function.	GLUD1 GLUD2	1.30e-05	2	126	2	11032875
Pubmed	Localization of Human Glutamate Dehydrogenases Provides Insights into Their Metabolic Role and Their Involvement in Disease Processes.	GLUD1 GLUD2	1.30e-05	2	126	2	29943084
Pubmed	Glutamate dehydrogenase deficiency disrupts glutamate homeostasis in hippocampus and prefrontal cortex and impairs recognition memory.	GLUD1 GLUD2	1.30e-05	2	126	2	31898404
Pubmed	Sortilin is a major protein component of Glut4-containing vesicles.	PTPRU SORT1	1.30e-05	2	126	2	9305862
Pubmed	Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux.	GLUD1 GLUD2	1.30e-05	2	126	2	15378063
Pubmed	Widening Spectrum of Cellular and Subcellular Expression of Human GLUD1 and GLUD2 Glutamate Dehydrogenases Suggests Novel Functions.	GLUD1 GLUD2	1.30e-05	2	126	2	27422263
Pubmed	Critical role of the cysteine 323 residue in the catalytic activity of human glutamate dehydrogenase isozymes.	GLUD1 GLUD2	1.30e-05	2	126	2	15750346
Pubmed	WNK3 interacts with NCC.	SLC12A3 WNK3	1.30e-05	2	126	2	27378340
Pubmed	Molecular cloning, structure and expression analysis of a full-length mouse brain glutamate dehydrogenase cDNA.	GLUD1 GLUD2	1.30e-05	2	126	2	1711373
Pubmed	The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice.	CNTNAP3B CNTNAP3	1.30e-05	2	126	2	31150793
Pubmed	Overlapping functions of the cell adhesion molecules Nr-CAM and L1 in cerebellar granule cell development.	NRCAM L1CAM	1.30e-05	2	126	2	11564762
Pubmed	Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate.	GLUD1 GLUD2	1.30e-05	2	126	2	20529287
Pubmed	Determination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry).	GLUD1 GLUD2	1.30e-05	2	126	2	25124006
Pubmed	Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase.	GLUD1 GLUD2	1.30e-05	2	126	2	23673664
Pubmed	Lack of evidence for direct ligand-gated ion channel activity of GluD receptors.	GLUD1 GLUD2	1.30e-05	2	126	2	39052831
Pubmed	Metabolism changes during aging in the hippocampus and striatum of glud1 (glutamate dehydrogenase 1) transgenic mice.	GLUD1 GLUD2	1.30e-05	2	126	2	24442550
Pubmed	The Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity.	GLUD1 GLUD2	1.30e-05	2	126	2	27137930
Pubmed	GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate Distribution.	GLUD1 GLUD2	1.30e-05	2	126	2	26440896
Pubmed	Study of structure-function relationships in human glutamate dehydrogenases reveals novel molecular mechanisms for the regulation of the nerve tissue-specific (GLUD2) isoenzyme.	GLUD1 GLUD2	1.30e-05	2	126	2	12742085
Pubmed	A single injection of gain-of-function mutant PCSK9 adeno-associated virus vector induces cardiovascular calcification in mice with no genetic modification.	LDLR SORT1	1.30e-05	2	126	2	27318830
Pubmed	CRTR-1, a developmentally regulated transcriptional repressor related to the CP2 family of transcription factors.	TFCP2 TFCP2L1	1.30e-05	2	126	2	11073954
Pubmed	A Mutation in Syne2 Causes Early Retinal Defects in Photoreceptors, Secondary Neurons, and Müller Glia.	IFNGR1 SYNE2	1.30e-05	2	126	2	26066746
Pubmed	The F2-isoprostane 8-iso-PGF2α attenuates atherosclerotic lesion formation in Ldlr-deficient mice - Potential role of vascular thromboxane A2 receptors.	TBXA2R LDLR	1.30e-05	2	126	2	35470061
Pubmed	Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries.	SORT1 LPA	1.30e-05	2	126	2	29973585
Pubmed	Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.	LDLR LPA	1.30e-05	2	126	2	24632281
Pubmed	Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro.	LPA LRP2	1.30e-05	2	126	2	10073957
Pubmed	Mitochondrial targeting adaptation of the hominoid-specific glutamate dehydrogenase driven by positive Darwinian selection.	GLUD1 GLUD2	1.30e-05	2	126	2	18688271
Pubmed	The complex regulation of human glud1 and glud2 glutamate dehydrogenases and its implications in nerve tissue biology.	GLUD1 GLUD2	1.30e-05	2	126	2	22658952
Pubmed	Increases in anterograde axoplasmic transport in neurons of the hyper-glutamatergic, glutamate dehydrogenase 1 (Glud1) transgenic mouse: Effects of glutamate receptors on transport.	GLUD1 GLUD2	1.30e-05	2	126	2	38124277
Pubmed	Deletion of glutamate dehydrogenase in beta-cells abolishes part of the insulin secretory response not required for glucose homeostasis.	GLUD1 GLUD2	1.30e-05	2	126	2	19015267
Pubmed	Human GLUD1 and GLUD2 glutamate dehydrogenase localize to mitochondria and endoplasmic reticulum.	GLUD1 GLUD2	1.30e-05	2	126	2	19448744
Pubmed	Localized reduction of atherosclerosis in von Willebrand factor-deficient mice.	VWF LDLR	1.30e-05	2	126	2	11520791
Pubmed	Single amino acid substitution (G456A) in the vicinity of the GTP binding domain of human housekeeping glutamate dehydrogenase markedly attenuates GTP inhibition and abolishes the cooperative behavior of the enzyme.	GLUD1 GLUD2	1.30e-05	2	126	2	11950837
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 CEP162 TBC1D5 RFX7 MEGF8 MTUS1 SYNE2 MPHOSPH9 PLEC PLCH1 WNK3 PHLDB2 OTOG	1.56e-05	861	126	13	36931259
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-7 ERVK-21 ERVK-9 ERVK-18 ERVK-24	2.44e-05	94	126	5	21542922
Pubmed	Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins.	FLT4 NTRK2 LRP1B LDLR LRP2	3.46e-05	101	126	5	23382219
Pubmed	A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses.	LDLR SORT1 LPA	3.64e-05	18	126	3	20971364
Pubmed	WNK4 enhances the degradation of NCC through a sortilin-mediated lysosomal pathway.	SORT1 SLC12A3	3.90e-05	3	126	2	19875813
Pubmed	The structure of apo human glutamate dehydrogenase details subunit communication and allostery.	GLUD1 GLUD2	3.90e-05	3	126	2	12054821
Pubmed	PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role.	LDLR LPA	3.90e-05	3	126	2	27102113
Pubmed	Trans-Synaptic Signaling through the Glutamate Receptor Delta-1 Mediates Inhibitory Synapse Formation in Cortical Pyramidal Neurons.	GLUD1 GLUD2	3.90e-05	3	126	2	31704028
Pubmed	The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex.	SLC12A3 WNK3	3.90e-05	3	126	2	17975670
Pubmed	Polymorphisms in PCSK9, LDLR, BCMO1, SLC12A3, and KCNJ1 are Associated with Serum Lipid Profile in Chinese Han Population.	LDLR SLC12A3	3.90e-05	3	126	2	31480784
Pubmed	Downregulation of VEGFR3 signaling alters cardiac lymphatic vessel organization and leads to a higher mortality after acute myocardial infarction.	FLT4 LDLR	3.90e-05	3	126	2	30420641
Pubmed	CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.	LDLR RASGRP2	3.90e-05	3	126	2	26988592
Pubmed	Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors.	NTRK2 SORT1	3.90e-05	3	126	2	25037567
Pubmed	Nr-CAM expression in the developing mouse nervous system: ventral midline structures, specific fiber tracts, and neuropilar regions.	NRCAM L1CAM	3.90e-05	3	126	2	11329126
Pubmed	Activation of TAK1 by Sef-S induces apoptosis in 293T cells.	NR2C2 IL17RD	3.90e-05	3	126	2	23770285
Pubmed	Expression of matrilin-1, -2 and -3 in developing mouse limbs and heart.	MATN2 MATN3	3.90e-05	3	126	2	11102754
Pubmed	Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis.	FLT4 LDLR	3.90e-05	3	126	2	24723556
Pubmed	Identification and characterization of an extramitochondrial human 3-hydroxy-3-methylglutaryl-CoA lyase.	HMGCL HMGCLL1	3.90e-05	3	126	2	22865860
Pubmed	Chromosome assignment of mouse insulin, colony stimulating factor 1, and low-density lipoprotein receptors.	LDLR CSF1R	3.90e-05	3	126	2	3066742
Pubmed	Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis.	LDLR SORT1	3.90e-05	3	126	2	25593281
Pubmed	Postsynaptic δ1 glutamate receptor assembles and maintains hippocampal synapses via Cbln2 and neurexin.	GLUD1 GLUD2	3.90e-05	3	126	2	29784783
Pubmed	Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve.	LDLR LPA	3.90e-05	3	126	2	26224810
Pubmed	Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival.	NTRK2 SORT1	3.90e-05	3	126	2	21966426
Pubmed	TFCP2/TFCP2L1/UBP1 transcription factors in cancer.	TFCP2 TFCP2L1	3.90e-05	3	126	2	29410248
Pubmed	Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient mice.	TBXA2R LDLR	3.90e-05	3	126	2	16267259
Pubmed	Glutamine-Elicited Secretion of Glucagon-Like Peptide 1 Is Governed by an Activated Glutamate Dehydrogenase.	GLUD1 GLUD2	3.90e-05	3	126	2	29229616
Pubmed	Renal and brain isoforms of WNK3 have opposite effects on NCCT expression.	SLC12A3 WNK3	3.90e-05	3	126	2	19470686
Pubmed	Liver Glutamate Dehydrogenase Controls Whole-Body Energy Partitioning Through Amino Acid-Derived Gluconeogenesis and Ammonia Homeostasis.	GLUD1 GLUD2	3.90e-05	3	126	2	30002133
Pubmed	Glutamate delta-1 receptor regulates cocaine-induced plasticity in the nucleus accumbens.	GLUD1 GLUD2	3.90e-05	3	126	2	30315226
Pubmed	The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity.	STAB2 VWF	3.90e-05	3	126	2	30124466
Pubmed	Bergmann glia and the recognition molecule CHL1 organize GABAergic axons and direct innervation of Purkinje cell dendrites.	NRCAM L1CAM	3.90e-05	3	126	2	18447583
Pubmed	Isolation of a human brain cDNA for glutamate dehydrogenase.	GLUD1 GLUD2	3.90e-05	3	126	2	3585334
Pubmed	GOT1 regulates CD8+ effector and memory T cell generation.	GLUD1 GLUD2	3.90e-05	3	126	2	36640309
Pubmed	Screening for new inhibitors of the human Mitochondrial Pyruvate Carrier and their effects on hepatic glucose production and diabetes.	GLUD1 GLUD2	3.90e-05	3	126	2	37871770
Pubmed	Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor.	LDLR LPA	3.90e-05	3	126	2	25778403
Pubmed	Deletion of glutamate delta-1 receptor in mouse leads to enhanced working memory and deficit in fear conditioning.	GLUD1 GLUD2	3.90e-05	3	126	2	23560106
Pubmed	Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report.	LDLR LRP2	3.90e-05	3	126	2	30567480
Interaction	EGFL6 interactions	ZZEF1 LRP1B LDLR LRP2	6.19e-06	21	118	4	int:EGFL6
Interaction	CBLN4 interactions	CNTNAP3B L1CAM CNTNAP3 TOPBP1 LAMB2 PTPRU MEGF8	9.87e-06	127	118	7	int:CBLN4
GeneFamily	Low density lipoprotein receptors	LRP1B LDLR LRP2	2.31e-05	13	80	3	634
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FLT4 NRCAM SPEG NTRK2 L1CAM HMCN2	7.92e-05	161	80	6	593
GeneFamily	SEC14 family\|PRELI domain containing	SEC14L5 SEC14L1	2.87e-04	6	80	2	1295
GeneFamily	SEC14 family\|PRELI domain containing	SEC14L5 SEC14L1	2.87e-04	6	80	2	1063
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	FLT4 NTRK2 CSF1R	7.32e-04	40	80	3	321
GeneFamily	Immunoglobulin like domain containing	FLT4 NRCAM LAG3 CSF1R HMCN2	1.66e-03	193	80	5	594
GeneFamily	DNA helicases	INO80 ASCC3	2.52e-03	17	80	2	1167
GeneFamily	EF-hand domain containing	ZZEF1 TBC1D8B NKD1 PLCH1 RASGRP2	2.87e-03	219	80	5	863
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRU PTPRR	3.84e-03	21	80	2	813
GeneFamily	WD repeat domain containing	TRAF7 APAF1 FBXW4 PPP2R2C DNAI4	6.11e-03	262	80	5	362
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	STAB2 CD163L1	6.32e-03	27	80	2	1253
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 NRCAM MUC5B NEB LRP1B LRP2 PLCH1 OTOG	4.08e-08	184	121	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 NRCAM MUC5B NEB LRP1B LRP2 PLCH1 OTOG	4.08e-08	184	121	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 NRCAM MUC5B NEB LRP1B LRP2 PLCH1 OTOG	4.08e-08	184	121	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Aorta\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBXA2R FLT4 PTPRU LIMS2 LRP2 TMEM26 OTOG	5.40e-07	176	121	7	0b3491451be02c18a16cdb875645be47eb867a7f
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	CNTNAP3B VWF LIMS2 PTPRR SYNE2 LNX1 SEC14L1	9.34e-07	191	121	7	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	COVID-19-kidney-Glomerular_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTNAP3B FLT4 LIMS2 KLHL5 SYNE2 TMEM26 SEC14L1	1.04e-06	194	121	7	660535b492445063d965095a50e1e299ce04c50a
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	CNTNAP3B FLT4 VWF LIMS2 SYNE2 LNX1 SEC14L1	1.07e-06	195	121	7	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	CNTNAP3B VWF LIMS2 KLHL5 SYNE2 LNX1 SEC14L1	1.07e-06	195	121	7	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	CNTNAP3B FLT4 VWF LIMS2 SYNE2 LNX1 SEC14L1	1.15e-06	197	121	7	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3B VWF NTRK2 CNTNAP3 LIMS2 MTUS1 PTPRR	1.23e-06	199	121	7	bd43a84e84d8acb8e1008b98a235cc5bd5f43586
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGSM1 LRP1B ADGRG4 TFCP2L1 SLC12A3 HMGCLL1	4.70e-06	158	121	6	7960337d87afecf2692ab65e5991f052ceddfacc
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PGLYRP4 LAG3 MUC5B ZNF829 MROH1 WNK3	7.64e-06	172	121	6	5401ac7739f95fb8681cfb4747ab6e447a3c2ae8
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PGLYRP4 LAG3 MUC5B ZNF829 MROH1 WNK3	7.64e-06	172	121	6	b3da7f488d191214d7bb74fbac189fe8c29ee6cd
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PGLYRP4 LAG3 MUC5B ZNF829 MROH1 WNK3	7.64e-06	172	121	6	74dd4a7acb2cf857fed20219e4d7dc1adfbaa398
ToppCell	droplet-Marrow-nan-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN2 FBXW4 ZZEF1 CSF1R MEGF8 THAP6	8.16e-06	174	121	6	55cc8300489d11322724159ec7d0e1d32a702e91
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B POTEG CNTNAP3 PDCL2 KLHL5 PLCH1	8.71e-06	176	121	6	322259a35f5c97d73ce7f75835dcdb5c954c91f8
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B FLT4 VWF LIMS2 KLHL5 SEC14L1	9.59e-06	179	121	6	8f9e538c822940785130297712b75131812a4603
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	VWF CNTNAP3 LIMS2 HMCN2 MTUS1 PTPRR	9.59e-06	179	121	6	8c9ed247e1c4d655b81ce2f24a9936a7cade718a
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 STAB2 APAF1 LAMB2 NKD1 ZNF287	1.02e-05	181	121	6	4df7972f88117108698efd06b124b232f8588981
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRAF7 FLT4 STAB2 ZGRF1 MTUS1 PHLDB2	1.02e-05	181	121	6	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 STAB2 APAF1 LAMB2 NKD1 ZNF287	1.02e-05	181	121	6	cbb530566893281289026bfd93adf721decd4ca3
ToppCell	5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 STAB2 VWF CNTNAP3 LAMB2 PHLDB2	1.05e-05	182	121	6	fd786c88826ad3d5cc5c3d80f8e392d6be1b5267
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 PDCL2 KLHL5 HMCN2 PLCH1	1.05e-05	182	121	6	08aff7112c9dac0ef5540300516a604782b21169
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CNTNAP3B FLT4 STAB2 CNTNAP3 MTUS1 PHLDB2	1.05e-05	182	121	6	53c267ee327e116dbd89d5927ed3bdf78d25ee62
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CNTNAP3B FLT4 STAB2 CNTNAP3 LAMB2 PHLDB2	1.09e-05	183	121	6	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 PDCL2 KLHL5 PLCH1 RASGRP2	1.12e-05	184	121	6	23515c28e1f42aab29cef9e5b4a7f45bda7f5520
ToppCell	5'-Adult-Appendix-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 STAB2 VWF CNTNAP3 LAMB2 PHLDB2	1.12e-05	184	121	6	453295362888c9a59d0e73c7a5b15914c50ff591
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FLT4 STAB2 VWF CNTNAP3 MTUS1 TMEM26	1.19e-05	186	121	6	e8ead5634686ebaa6a230eea69795d923ce9939d
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTNAP3B VWF MATN2 CNTNAP3 LIMS2 MTUS1	1.31e-05	189	121	6	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF CNTNAP3 LIMS2 MTUS1 SYNE2 SEC14L1	1.39e-05	191	121	6	adb2e3efcad02889d8229325080da5e7830fd3ae
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 PDCL2 KLHL5 PLCH1 RASGRP2	1.39e-05	191	121	6	782bc7946417549ffd39e5b596db659436fa01ba
ToppCell	COPD-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	ENTPD7 TMEM156 CD1C KLHL5 NKD1 SEC14L1	1.43e-05	192	121	6	984cdc2f1d93e164bc946d63f58dacb629f82eb7
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTNAP3B FLT4 LIMS2 KLHL5 SYNE2 SEC14L1	1.43e-05	192	121	6	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	droplet-Lung-nan-18m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF LIMS2 KLHL5 CLCA1 NKD1 PTPRR	1.43e-05	192	121	6	45929c757d873fe314cc36d27abd265414635490
ToppCell	IPF-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	SPEG NTRK2 LIMS2 SORT1 NKD1 RASGRP2	1.43e-05	192	121	6	9b06c7336624ef21f8e5393725b56038a8028e57
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	VWF LIMS2 PTPRR SYNE2 LNX1 SEC14L1	1.43e-05	192	121	6	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	droplet-Lung-nan-18m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF LIMS2 KLHL5 CLCA1 NKD1 PTPRR	1.43e-05	192	121	6	beb336d3479821bdab7e8e2c58812f155e44e9a2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B FLT4 VWF LIMS2 KLHL5 SEC14L1	1.43e-05	192	121	6	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B FLT4 VWF LIMS2 KLHL5 SEC14L1	1.47e-05	193	121	6	52e918884877b6659cdca0496390e440f73694a9
ToppCell	RV-09._Endothelium_I\|World / Chamber and Cluster_Paper	FLT4 VWF LIMS2 SYNE2 LNX1 SEC14L1	1.47e-05	193	121	6	e3fa47e2c7cd8a5b69186711c57751f2296de8ae
ToppCell	droplet-Kidney-nan-21m-Endothelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBXA2R FLT4 LAMB2 PTPRU LIMS2 PTPRR	1.47e-05	193	121	6	0e39b6c8e7382e61a9891f6c7e3df2a859788219
ToppCell	RV-09._Endothelium_I\|RV / Chamber and Cluster_Paper	FLT4 VWF LIMS2 SYNE2 LNX1 SEC14L1	1.51e-05	194	121	6	7b408096e717f2327c12aea35a8d5fc4621d3b06
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NTRK2 PTPRU LIMS2 KLHL5 NKD1 PHLDB2	1.51e-05	194	121	6	e30a3765feae5cd10ddba16a166c31eb5717edd3
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TBXA2R CNTNAP3B FLT4 LIMS2 KLHL5 SEC14L1	1.51e-05	194	121	6	74a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell	IPF-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	ENTPD7 TMEM156 CD1C KLHL5 NKD1 SEC14L1	1.51e-05	194	121	6	accf4b7b09e2048f2e47a52201e0158684dda8fe
ToppCell	droplet-Lung-nan-18m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF NTRK2 PTPRU LIMS2 KLHL5 NKD1	1.51e-05	194	121	6	faaa7f18667e8943528fd0e92b7988e5b0607b54
ToppCell	droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF LIMS2 KLHL5 CLCA1 NKD1 PTPRR	1.56e-05	195	121	6	0c15be3e7c238e329505dcbbe197a977d1019d45
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	DNAH3 MUC5B LRGUK SYNE2 DNAI4 PLCH1	1.56e-05	195	121	6	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_venous_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B FLT4 STAB2 VWF CNTNAP3 LIMS2	1.56e-05	195	121	6	ca2cf2c10db1ad17aa0a2e30aa7079a7ad751ea6
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	VWF LIMS2 KLHL5 SYNE2 LNX1 SEC14L1	1.56e-05	195	121	6	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B VWF LIMS2 HMCN2 MTUS1 SEC14L1	1.56e-05	195	121	6	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	droplet-Lung-18m-Endothelial-venous_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF LIMS2 KLHL5 CLCA1 NKD1 PTPRR	1.56e-05	195	121	6	45ac0fdbeb0982d798c613a6d15715d725608aa9
ToppCell	droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF LIMS2 KLHL5 CLCA1 NKD1 PTPRR	1.56e-05	195	121	6	5b1f04a745467876b09113ee17ababd3fcf9fb01
ToppCell	PCW_13-14-Endothelial-Endothelial_mature\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B FLT4 VWF NTRK2 CNTNAP3 LIMS2	1.56e-05	195	121	6	31353269591c9eee84872838e91995d4a035da46
ToppCell	PCW_10-12-Endothelial-Endothelial_mature\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B FLT4 VWF NTRK2 CNTNAP3 LIMS2	1.61e-05	196	121	6	481d79bdaec069ad2746a28d39eeee8d3edf7305
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B FLT4 VWF LIMS2 KLHL5 SEC14L1	1.61e-05	196	121	6	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B FLT4 VWF LIMS2 KLHL5 SEC14L1	1.61e-05	196	121	6	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	Endothelial\|World / Lineage, Cell type, age group and donor	CNTNAP3B FLT4 STAB2 VWF LIMS2 SEC14L1	1.61e-05	196	121	6	96c6d78482a130ce4e29f6629972a06d10d7530e
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	FLT4 LRP1B KLHL5 SYNE2 TMEM26 SEC14L1	1.61e-05	196	121	6	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	COPD-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	VWF NTRK2 LIMS2 IFNGR1 KLHL5 SEC14L1	1.65e-05	197	121	6	30dbc05ea66892d2e18ff375ffa86d1db7bc4083
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3B SPEG NTRK2 MATN2 CNTNAP3 LIMS2	1.65e-05	197	121	6	f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FLT4 STAB2 VWF CNTNAP3 MTUS1 PHLDB2	1.65e-05	197	121	6	4e58bbf3ecb30b4c8199adcc04d2eb134d90de56
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	CNTNAP3B VWF NTRK2 LIMS2 SYNE2 SEC14L1	1.65e-05	197	121	6	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	VWF LIMS2 KLHL5 SYNE2 LNX1 SEC14L1	1.65e-05	197	121	6	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	5'-Adult-Appendix-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 STAB2 VWF CNTNAP3 MTUS1 PHLDB2	1.70e-05	198	121	6	90e85fe7a0ab376a41666dfff6c0e95b7f1c9475
ToppCell	Parenchymal-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3B FLT4 VWF NTRK2 LIMS2 SEC14L1	1.75e-05	199	121	6	a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e
ToppCell	distal-Endothelial-Capillary-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	VWF NTRK2 LIMS2 IFNGR1 KLHL5 SEC14L1	1.75e-05	199	121	6	d27fbd9a651821b2859dfa80bce4e6fc6f8299fc
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B NTRK2 CNTNAP3 PDCL2 KLHL5 PLCH1	1.80e-05	200	121	6	5ec469267747dce3601c1d8ad01af89fa5b29acc
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B NTRK2 CNTNAP3 PDCL2 KLHL5 PLCH1	1.80e-05	200	121	6	e79d93d55b25804f2608185168da472301b6ebca
ToppCell	10x5'v1-week_14-16-Endothelial-stroma-sinusoidal_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FLT4 STAB2 VWF CNTNAP3 MTUS1 PHLDB2	1.80e-05	200	121	6	ae429f2de652cc1976e63644781197e9ce0e70c8
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RALGAPA1 VWF LIMS2 MTUS1 SYNE2 GLUD1	1.80e-05	200	121	6	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B NTRK2 CNTNAP3 PDCL2 KLHL5 PLCH1	1.80e-05	200	121	6	320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c
ToppCell	facs-Aorta-Heart-3m-Endothelial-coronary_vascular_endothelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HENMT1 TFCP2L1 PTPRR PLCH1 LNX1	3.05e-05	132	121	5	dc13b54e38fbda9341972cef11833041f2f2a345
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCAF1 SPACA9 PTPRU MPHOSPH9 TMEM26	4.32e-05	142	121	5	d52da766e031f7409eb5a7a9fa88f48e14a79d8b
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Epi-like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCAF1 SPACA9 PTPRU MPHOSPH9 TMEM26	4.32e-05	142	121	5	a05b320cf182b2aaf18df7c40045dc65b659bf20
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TRAF7 CNTNAP3B VWF CNTNAP3 CLEC2L	4.62e-05	144	121	5	748f4efc59f7afbce6c497524f36d852b8b1d637
ToppCell	COVID-19-kidney-Mito-rich_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTNAP3B FLT4 SYNE2 OTOG SEC14L1	4.78e-05	145	121	5	afed661aef990edb8e7012ab67ace56443520c9f
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	FLT4 NTRK2 NKD1 MEGF8 IL17RD	6.16e-05	153	121	5	e7d20c88466ff81db613869cf7a6a4bb95fd6c2f
ToppCell	severe_COVID-19-MAIT\|World / disease group, cell group and cell class (v2)	CNKSR1 FLT4 MATN2 MTUS1 SEC14L5	6.36e-05	154	121	5	65ec7f7ef05c589903c4c9fe3849478c325fdc61
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CEP162 ZGRF1 NTRK2 CLCA1 IL17RD	8.31e-05	163	121	5	3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622
ToppCell	primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TBXA2R LAMB2 LIMS2 NKD1 PHLDB2	8.56e-05	164	121	5	9eed945e9b0c1ee5fc62724ac2bbbed4267b0678
ToppCell	primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TBXA2R LAMB2 LIMS2 NKD1 PHLDB2	8.56e-05	164	121	5	f510f20e37e31b486cdd0e3f597ce4ff00877c5d
ToppCell	primary_visual_cortex-Non-neuronal-smooth_muscle_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TBXA2R LAMB2 LIMS2 NKD1 PHLDB2	8.56e-05	164	121	5	5c932a462cbf81d029c8d11ec3aea3191529527b
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLT4 STAB2 NCAPG2 CLCA1 MPHOSPH9	8.81e-05	165	121	5	50a8513d8d2630861499393a7f102b35366bad37
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B VWF LIMS2 HMCN2 SEC14L1	9.06e-05	166	121	5	8e2faca6a2e76a625de04d6098aa6f98911945c6
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3B VWF CNTNAP3 LIMS2 PTPRR	9.32e-05	167	121	5	d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCell	facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 VWF PTPRU HMGCLL1 PHLDB2	9.59e-05	168	121	5	06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46
ToppCell	facs-Heart-RA-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 VWF PTPRU HMGCLL1 PHLDB2	9.59e-05	168	121	5	1002f058a340763e3d8de0bd1f0547a903526ec6
ToppCell	356C-Endothelial_cells-Endothelial-B_(Artery)\|356C / Donor, Lineage, Cell class and subclass (all cells)	CNTNAP3B VWF MATN2 OVOS2 PTPRR	9.86e-05	169	121	5	605cc2638271803cf1d972ab3fa8f13f89666376
ToppCell	356C-Endothelial_cells-Endothelial-B_(Artery)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	CNTNAP3B VWF MATN2 OVOS2 PTPRR	9.86e-05	169	121	5	337be3bf485b54afad86e256cb0c4c1d0c2a9a2a
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9\|TCGA-Bladder / Sample_Type by Project: Shred V9	ENTPD7 MR1 TBC1D8B FAT2 MTUS1	1.04e-04	171	121	5	adbcfa4bf6bc1c604535a24435924cdb091e2dd7
ToppCell	3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 SGSM1 STAB2 CNTNAP3 MTUS1	1.10e-04	173	121	5	85083b9ce20351dd69aa2327ad087b848b4307ff
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TBXA2R FLT4 STAB2 CNTNAP3 PHLDB2	1.16e-04	175	121	5	43be63976da5ad0764d24d90919a77ce46068f52
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D175\|Adult / Lineage, Cell type, age group and donor	CNTNAP3B VWF MATN2 LRP1B LIMS2	1.16e-04	175	121	5	0a65ddfa8c2e8efb5b5338cf07661cb78157a23c
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF LIMS2 CLCA1 PTPRR PLEC	1.19e-04	176	121	5	77516048aefbe1f48e825052756df0c310c1c486
ToppCell	facs-Pancreas-Endocrine-18m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBXA2R FLT4 LIMS2 TMEM26 RASGRP2	1.19e-04	176	121	5	9ddf87e586d2378984cd007c60f7dc254845f8f3
ToppCell	facs-Pancreas-Endocrine-18m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBXA2R FLT4 LIMS2 TMEM26 RASGRP2	1.19e-04	176	121	5	e987e741fcf1bed8598a5060700efd3018f8123b
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VWF LAG3 CNTNAP3 ZNF284 PLEC	1.19e-04	176	121	5	1df7b6ce2519ad99bacbbaf1a8d5929e11513faa
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	VWF CNTNAP3 LIMS2 HMCN2 PTPRR	1.19e-04	176	121	5	52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a
ToppCell	facs-Pancreas-Endocrine-18m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBXA2R FLT4 LIMS2 TMEM26 RASGRP2	1.19e-04	176	121	5	92ebcea9b2b22601234b76d7a98f0410b905a87b
Drug	Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; PC3; HT_HG-U133A	DCAF1 NTRK2 PTPRU LDLR TFCP2L1 CSF1R PLCH1 ELL SEC14L5	1.16e-06	198	121	9	4071_UP
Drug	Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; PC3; HT_HG-U133A	ENTPD7 CEP162 MR1 LAMB2 TBC1D8B ZKSCAN5 LDLR COQ7	6.72e-06	185	121	8	7402_UP
Drug	Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; PC3; HT_HG-U133A	ENTPD7 STAB2 MATN3 ZZEF1 ZKSCAN5 CLCA1 ELL RASGRP2	1.03e-05	196	121	8	7400_UP
Drug	Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A	RALGAPA1 FLT4 NTRK2 APAF1 MR1 RNASEL SEC14L5 ZNF639	1.06e-05	197	121	8	7411_UP
Drug	Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; PC3; HT_HG-U133A	NTRK2 MATN3 TFCP2L1 RNASEL CLCA1 CSF1R PTPRR ZNF639	1.06e-05	197	121	8	5747_UP
Drug	Hydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; PC3; HT_HG-U133A	NTRK2 APAF1 SPACA9 PTPRR DNAI4 ELL COQ7 SEC14L5	1.06e-05	197	121	8	4489_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A	ENTPD7 RALGAPA1 FLT4 NRCAM APAF1 SPACA9 NEB LRP2	1.10e-05	198	121	8	4464_DN
Drug	rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A	CEP162 APAF1 SPACA9 SORT1 RNASEL SLC12A3 MEGF8 PLEC	1.14e-05	199	121	8	5927_UP
Drug	Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; PC3; HT_HG-U133A	DNAH3 CEP162 APAF1 MUC5B SPACA9 LIMS2 TFCP2L1 MEGF8	1.19e-05	200	121	8	3682_DN
Drug	monatepil	LRP1B LDLR LPA LRP2	1.63e-05	29	121	4	CID000060810
Drug	phenyltriethoxysilane	GLUD1 GLUD2	2.80e-05	2	121	2	CID000013075
Drug	G-3SH	GLUD1 GLUD2	2.80e-05	2	121	2	CID000174237
Drug	iodoacetyldiethylstilbestrol	GLUD1 GLUD2	2.80e-05	2	121	2	CID006455327
Drug	methylmercuric bromide	GLUD1 GLUD2	2.80e-05	2	121	2	CID000068175
Drug	5-methylisophthalate	GLUD1 GLUD2	2.80e-05	2	121	2	CID000068137
Drug	pentacosene	SEC14L5 SEC14L1	2.80e-05	2	121	2	CID000528972
Drug	x 1 s	GLUD1 GLUD2	2.80e-05	2	121	2	CID000409694
Drug	Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; MCF7; HT_HG-U133A	ENTPD7 RALGAPA1 TBC1D5 NEB LDLR CLCA1 ELL	3.28e-05	168	121	7	3443_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	TBC1D5 NOL6 SENP6 PLEC SNAPC3 COQ7 RASGRP2	7.15e-05	190	121	7	1306_DN
Drug	AC1L1A5E	GLUD1 GLUD2 IL17RD	7.80e-05	16	121	3	CID000000843
Drug	Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A	NR2C2 STAB2 MR1 SPACA9 NEB ZKSCAN5 SNAPC3	7.89e-05	193	121	7	7385_UP
Drug	Grgds	TBXA2R VWF SPEG LAG3 LAMB2	8.14e-05	83	121	5	CID000123811
Drug	splitomicin; Up 200; 20uM; PC3; HG-U133A	CNKSR1 SPEG FBXW4 POGZ RGP1 TFCP2 COQ7	8.15e-05	194	121	7	661_UP
Drug	Idoxuridine [54-42-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	TBXA2R NTRK2 TFCP2L1 PTPRR SENP6 COQ7 ZNF639	8.15e-05	194	121	7	4200_UP
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	DNAH3 CEP162 MR1 ZKSCAN5 SENP6 PLEC PLCH1	8.15e-05	194	121	7	3539_DN
Drug	lenthionine	GLUD1 GLUD2	8.37e-05	3	121	2	CID000067521
Drug	mildiomycin	GLUD1 GLUD2	8.37e-05	3	121	2	CID000125665
Drug	methoxyethylmercury	GLUD1 GLUD2	8.37e-05	3	121	2	CID000115155
Drug	4-methylumbelliferyl laurate	GLUD1 GLUD2	8.37e-05	3	121	2	CID000600674
Drug	methylmercuric iodide	GLUD1 GLUD2	8.37e-05	3	121	2	CID000067347
Drug	Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A	DCAF1 APAF1 TFCP2L1 MEGF8 ELL ZNF287 ZNF639	8.41e-05	195	121	7	3670_DN
Drug	Trimethoprim [738-70-5]; Up 200; 13.8uM; PC3; HT_HG-U133A	MR1 SPACA9 ZKSCAN5 TFCP2 SENP6 ELL COQ7	8.41e-05	195	121	7	7377_UP
Drug	Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; PC3; HT_HG-U133A	DCAF1 MUC5B ZKSCAN5 SORT1 TFCP2L1 LRP2 DNAI4	8.69e-05	196	121	7	4482_UP
Drug	Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A	TBXA2R STAB2 MUC5B ZZEF1 LDLR CLCA1 ELL	8.69e-05	196	121	7	3360_UP
Drug	Florfenicol [73231-34-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ZKSCAN5 TSPAN3 IFNGR1 SNAPC3 ELL COQ7 SEC14L1	8.69e-05	196	121	7	6460_DN
Drug	Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A	DCAF1 RALGAPA1 CEP162 NTRK2 MR1 LAMB2 NEB	8.69e-05	196	121	7	4720_UP
Drug	Spironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A	TBXA2R FLT4 APAF1 TFCP2L1 MEGF8 PTPRR COQ7	8.69e-05	196	121	7	5781_UP
Drug	Lovastatin [75330-75-5]; Up 200; 9.8uM; PC3; HT_HG-U133A	TBXA2R STAB2 SPEG APAF1 SORT1 LRP2 ZNF639	8.69e-05	196	121	7	6633_UP
Drug	Suprofen [40828-46-4]; Up 200; 15.4uM; PC3; HT_HG-U133A	TBXA2R SPACA9 ZZEF1 TFCP2L1 CSF1R SEC14L5 ZNF639	8.69e-05	196	121	7	4005_UP
Drug	Nialamide [51-12-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A	TBXA2R RALGAPA1 FLT4 SORT1 SEC14L5 ZNF639 RASGRP2	8.69e-05	196	121	7	3871_UP
Drug	Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A	TBXA2R RALGAPA1 NTRK2 MR1 PTPRU DNAI4 ZNF639	8.97e-05	197	121	7	3214_UP
Drug	2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A	DCAF1 SPACA9 LIMS2 RNASEL PTPRR DNAI4 ELL	8.97e-05	197	121	7	4433_UP
Drug	Etofylline [519-37-9]; Up 200; 17.8uM; MCF7; HT_HG-U133A	ENTPD7 TBXA2R NTRK2 TBC1D5 CLCA1 DNAI4 ELL	8.97e-05	197	121	7	5467_UP
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; PC3; HT_HG-U133A	FLT4 CEP162 MUC5B LIMS2 SENP6 PLCH1 ELL	8.97e-05	197	121	7	6741_DN
Drug	Androsterone [53-41-8]; Up 200; 13.8uM; PC3; HT_HG-U133A	TBXA2R SPEG SPACA9 PTPRU ZKSCAN5 MTUS1 COQ7	8.97e-05	197	121	7	4635_UP
Drug	Vinpocetine [42971-09-5]; Up 200; 11.4uM; PC3; HT_HG-U133A	ENTPD7 FLT4 STAB2 TBC1D5 PTPRU RFX7 PLCH1	8.97e-05	197	121	7	5859_UP
Drug	Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; PC3; HT_HG-U133A	TBXA2R SPEG PTPRU ZZEF1 LRP2 SENP6 ELL	8.97e-05	197	121	7	4186_UP
Drug	Ceftazidime pentahydrate [78439-06-2]; Up 200; 6.2uM; PC3; HT_HG-U133A	SPEG MATN3 APAF1 POGZ ZZEF1 RNASEL DNAI4	8.97e-05	197	121	7	5054_UP
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A	STAB2 NTRK2 APAF1 PTPRU CLCA1 LRP2 SEC14L5	8.97e-05	197	121	7	4507_UP
Drug	Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; PC3; HT_HG-U133A	PGLYRP4 MATN3 LAG3 ZZEF1 TBC1D8B SENP6 COQ7	8.97e-05	197	121	7	5076_UP
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; PC3; HT_HG-U133A	NRCAM MUC5B SPACA9 POGZ TFCP2L1 MEGF8 ZNF639	8.97e-05	197	121	7	5751_UP
Drug	Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A	TBXA2R MR1 NEB LIMS2 CLCA1 MEGF8 ZNF639	9.26e-05	198	121	7	3215_UP
Drug	Imidurea [39236-46-9]; Up 200; 10.4uM; PC3; HT_HG-U133A	TBXA2R NTRK2 MATN3 APAF1 SPACA9 PTPRU COQ7	9.26e-05	198	121	7	5062_UP
Drug	Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; PC3; HT_HG-U133A	TBXA2R FLT4 APAF1 LAG3 TFCP2L1 SLC12A3 ZNF639	9.26e-05	198	121	7	5782_UP
Drug	Brompheniramine maleate [980-71-2]; Up 200; 9.2uM; PC3; HT_HG-U133A	CEP162 NTRK2 CLCA1 PTPRR SENP6 SEC14L5 ZNF639	9.26e-05	198	121	7	4013_UP
Drug	Chloramphenicol [56-75-7]; Up 200; 12.4uM; PC3; HT_HG-U133A	SPEG NTRK2 MATN3 APAF1 PTPRU LRP2 COQ7	9.26e-05	198	121	7	5047_UP
Drug	Nilutamide [63612-50-0]; Up 200; 12.6uM; HL60; HT_HG-U133A	SPEG NTRK2 NOL6 LIMS2 SORT1 MTUS1 DNAI4	9.26e-05	198	121	7	3104_UP
Drug	Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; PC3; HT_HG-U133A	NTRK2 APAF1 PTPRU ZZEF1 SORT1 PTPRR LRP2	9.26e-05	198	121	7	4492_UP
Drug	Nifurtimox [23256-30-6]; Down 200; 14uM; MCF7; HT_HG-U133A	MR1 NEB SENP6 PLEC SNAPC3 PLCH1 SEC14L1	9.26e-05	198	121	7	7328_DN
Drug	Repaglinide [135062-02-1]; Up 200; 8.8uM; PC3; HT_HG-U133A	STAB2 MATN3 RFX7 CD1C PTPRR LRP2 DNAI4	9.26e-05	198	121	7	5862_UP
Drug	Doxylamine succinate [562-10-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	NRCAM NTRK2 TFCP2 TFCP2L1 SLC12A3 PTPRR LRP2	9.26e-05	198	121	7	4235_UP
Drug	Corticosterone [50-22-6]; Up 200; 11.6uM; PC3; HT_HG-U133A	TBXA2R NTRK2 SPACA9 PLCH1 SEC14L5 ZNF639 RASGRP2	9.26e-05	198	121	7	4064_UP
Drug	Proglumide [6620-60-6]; Up 200; 12uM; PC3; HT_HG-U133A	DCAF1 NRCAM NTRK2 APAF1 LAG3 PLCH1 ZNF639	9.55e-05	199	121	7	4337_UP
Drug	3-nitropropionic acid; Up 200; 10uM; PC3; HT_HG-U133A	TBXA2R CEP162 MR1 RGP1 ZZEF1 PLCH1 ZNF639	9.55e-05	199	121	7	6407_UP
Drug	Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; PC3; HT_HG-U133A	FLT4 MATN3 ZKSCAN5 LIMS2 PTPRR SENP6 ZNF639	9.55e-05	199	121	7	6640_DN
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A	TBXA2R PGLYRP4 MATN3 APAF1 TBC1D8B PTPRR LRP2	9.55e-05	199	121	7	5079_UP
Drug	rotenone; Up 200; 1uM; PC3; HT_HG-U133A	NTRK2 LIMS2 RNASEL CSF1R MTUS1 PTPRR SENP6	9.55e-05	199	121	7	5920_UP
Drug	Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; PC3; HT_HG-U133A	TBXA2R CEP162 APAF1 SPACA9 TFCP2L1 SENP6 ZNF287	9.55e-05	199	121	7	3698_DN
Drug	Mephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A	RALGAPA1 MR1 SPACA9 ZKSCAN5 MTUS1 PTPRR ELL	9.55e-05	199	121	7	7374_UP
Drug	methyl benzoquate	GLUD1 GLUD2	1.67e-04	4	121	2	CID000026383
Drug	pentenoic acid	GLUD1 GLUD2	1.67e-04	4	121	2	CID000012299
Drug	alpha-ketoglutaramate	GLUD1 GLUD2	1.67e-04	4	121	2	CID000000048
Drug	ureidoglycine	GLUD1 GLUD2	1.67e-04	4	121	2	CID000439649
Drug	Ivin	GLUD1 GLUD2	1.67e-04	4	121	2	CID000014083
Drug	8-BDB-TADP	GLUD1 GLUD2	1.67e-04	4	121	2	CID000130791
Drug	cadina-3,9-diene	GLUD1 GLUD2	1.67e-04	4	121	2	CID000010657
Drug	AC1L9CUQ	GLUD1 GLUD2	1.67e-04	4	121	2	CID000442451
Drug	luxabendazole	GLUD1 GLUD2	1.67e-04	4	121	2	CID000072019
Drug	N-butylmaleimide	GLUD1 GLUD2	1.67e-04	4	121	2	CID000239780
Drug	alpha-methylglutamate	GLUD1 GLUD2	1.67e-04	4	121	2	CID000095440
Drug	2b E2	GLUD1 GLUD2	1.67e-04	4	121	2	CID005327076
Drug	1,2-cyclohexanedione	LDLR LPA GLUD1 GLUD2	2.58e-04	58	121	4	CID000013006
Drug	bathocuproine	GLUD1 GLUD2	2.77e-04	5	121	2	CID000065149
Drug	AC1NRA4I	GLUD1 GLUD2	2.77e-04	5	121	2	CID005287695
Drug	isosteviol lactone	GLUD1 GLUD2	2.77e-04	5	121	2	CID000401559
Drug	1-pheg	GLUD1 GLUD2	2.77e-04	5	121	2	CID000152041
Drug	5'-FSBAzA	GLUD1 GLUD2	2.77e-04	5	121	2	CID000130430
Drug	Advicor	LPA SYNE2	2.77e-04	5	121	2	CID000151176
Drug	adenine N1-oxide	GLUD1 GLUD2	2.77e-04	5	121	2	CID000093557
Drug	choline sulfate	GLUD1 GLUD2	2.77e-04	5	121	2	CID000000485
Drug	l-413	GLUD1 GLUD2	2.77e-04	5	121	2	CID000012475
Drug	3-aminopicolinate	GLUD1 GLUD2	2.77e-04	5	121	2	CID000073836
Drug	phthalic acid	SPEG APAF1 LDLR GLUD1 GLUD2	2.93e-04	109	121	5	CID000001017
Drug	CAS 79547-78-7	TBXA2R SORT1 TPSD1	3.09e-04	25	121	3	CID000003915
Drug	GN-F	L1CAM LDLR TFCP2	3.09e-04	25	121	3	CID006420159
Drug	Gg P	TBXA2R GLUD1 GLUD2	3.09e-04	25	121	3	CID005288387
Drug	isophthalate	LAG3 GLUD1 GLUD2	3.48e-04	26	121	3	CID000008496
Drug	Air Pollutants	VWF TBC1D5 MATN2 APAF1 MR1 HMGCL NEB TBC1D8B LIMS2 IFNGR1 ABRAXAS1 SYNE2 PLCH1 ZNF287	3.71e-04	917	121	14	ctd:D000393
Drug	alpha-monofluoromethylputrescine	GLUD1 GLUD2	4.14e-04	6	121	2	CID000134201
Drug	dimethylmalonate	GLUD1 GLUD2	4.14e-04	6	121	2	CID000007943
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	FLT4 L1CAM APAF1 LRP1B SYNE2 WNK3	2.85e-05	148	117	6	C0279702
Disease	fascioliasis (biomarker_via_orthology)	GLUD1 GLUD2	4.66e-05	3	117	2	DOID:885 (biomarker_via_orthology)
Disease	bipolar disorder (is_marker_for)	VWF NTRK2 L1CAM	5.62e-05	19	117	3	DOID:3312 (is_marker_for)
Disease	childhood absence epilepsy (biomarker_via_orthology)	GLUD1 GLUD2	2.31e-04	6	117	2	DOID:1825 (biomarker_via_orthology)
Disease	temporal lobe epilepsy (biomarker_via_orthology)	NTRK2 GLUD1 GLUD2	2.52e-04	31	117	3	DOID:3328 (biomarker_via_orthology)
Disease	MASA syndrome (implicated_via_orthology)	NRCAM L1CAM	3.23e-04	7	117	2	DOID:0060246 (implicated_via_orthology)
Disease	Cardiovascular Diseases	VWF SORT1 LPA	3.94e-04	36	117	3	C0007222
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3	4.30e-04	8	117	2	DOID:0060308 (implicated_via_orthology)
Disease	triacylglycerol 58:12 measurement	MATN2 LNX1	1.00e-03	12	117	2	EFO_0010439
Disease	factor VIII measurement, coronary artery disease	STAB2 VWF LPA ELL	1.08e-03	113	117	4	EFO_0001645, EFO_0004630
Disease	immature platelet fraction	VWF TBC1D5 PLEC SEC14L5	1.12e-03	114	117	4	EFO_0009187
Disease	cortisol measurement, response to corticosteroid, response to synacthen	ANKS1B LRP1B	1.18e-03	13	117	2	EFO_0005843, EFO_0009175, GO_0031960
Disease	von Willebrand factor measurement, coronary artery disease	STAB2 VWF LPA ELL	1.27e-03	118	117	4	EFO_0001645, EFO_0004629
Disease	immature platelet measurement	VWF TBC1D5 PLEC SEC14L5	1.31e-03	119	117	4	EFO_0803541
Disease	factor VII activating protease measurement	SGSM1 NOL6 METTL25	1.37e-03	55	117	3	EFO_0009368
Disease	membranous glomerulonephritis (biomarker_via_orthology)	PTPRU LRP2	1.38e-03	14	117	2	DOID:10976 (biomarker_via_orthology)
Disease	triglycerides in LDL measurement	LDLR LPA SYNE2	1.45e-03	56	117	3	EFO_0022320
Disease	Proteinuria	VWF LRP2	1.58e-03	15	117	2	HP_0000093
Disease	response to statin, LDL cholesterol change measurement	LDLR LPA	1.58e-03	15	117	2	EFO_0007804, GO_0036273
Disease	hepatic encephalopathy (biomarker_via_orthology)	GLUD1 GLUD2	1.58e-03	15	117	2	DOID:13413 (biomarker_via_orthology)
Disease	Sarcomatoid Renal Cell Carcinoma	L1CAM APAF1 LRP1B SYNE2	1.72e-03	128	117	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	L1CAM APAF1 LRP1B SYNE2	1.72e-03	128	117	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	L1CAM APAF1 LRP1B SYNE2	1.72e-03	128	117	4	C1266044
Disease	Papillary Renal Cell Carcinoma	L1CAM APAF1 LRP1B SYNE2	1.72e-03	128	117	4	C1306837
Disease	Renal Cell Carcinoma	L1CAM APAF1 LRP1B SYNE2	1.72e-03	128	117	4	C0007134
Disease	creatinine measurement	SPEG INO80 NEB LDLR TFCP2L1 LPA LRP2 DNAI4 PLEC ASCC3 ELL	2.04e-03	995	117	11	EFO_0004518
Disease	Coronary Arteriosclerosis	LDLR SORT1 LPA	2.22e-03	65	117	3	C0010054
Disease	susceptibility to cold sores measurement	TBC1D5 NKD1 HMGCLL1	2.22e-03	65	117	3	EFO_0008402
Disease	susceptibility to vaginal yeast infection measurement	NTRK2 ANKS1B MTUS1	2.22e-03	65	117	3	EFO_0008412
Disease	Coronary Artery Disease	LDLR SORT1 LPA	2.22e-03	65	117	3	C1956346
Disease	factor VIII measurement, Ischemic stroke	STAB2 VWF	2.55e-03	19	117	2	EFO_0004630, HP_0002140
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	LDLR LPA	3.12e-03	21	117	2	EFO_0022246
Disease	autism spectrum disorder (implicated_via_orthology)	CNTNAP3B NRCAM CNTNAP3 POGZ	3.20e-03	152	117	4	DOID:0060041 (implicated_via_orthology)
Disease	electroencephalogram measurement	DNAH3 SGSM1 PPP2R2C	3.21e-03	74	117	3	EFO_0004357
Disease	nephrosis (biomarker_via_orthology)	PTPRU LRP2	3.42e-03	22	117	2	DOID:2527 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VQRQLHCCGIHNYSD	TSPAN3	141	O60637
VSKSSCNYNHHLDVV	ABRAXAS1	306	Q6UWZ7
LVHTYDEHSEQVNCC	APAF1	691	O14727
GHTYHINSISVNSDC	PPP2R2C	171	Q9Y2T4
ETCHSSLYEQSCEAH	CNTNAP3	581	Q9BZ76
SLYEQSCEAHKHRGN	CNTNAP3	586	Q9BZ76
DFCITPQIYNESEHH	ERVK-18	446	O42043
DFCITPQIYNESEHH	ERVK-9	556	Q9UKH3
IQQYVSSHGEVHLDC	ELL	96	P55199
VNYTICQCDHLTHFG	ADGRG4	2711	Q8IZF6
TEYNGTDNCTAHEHN	GKAP1	231	Q5VSY0
NHDCSHNEDVTLTCY	CD163L1	241	Q9NR16
NGSAILHTYTHVDEC	MUC5B	5721	Q9HC84
QSGCYHHCVDENIER	NKD1	241	Q969G9
HSVCVNQIVCGYAHT	RCBTB1	231	Q8NDN9
YSCRSNQDCIINKHH	NR2C2	151	P49116
HCKAVSGYSDQVVHQ	INO80	976	Q9ULG1
LTFCNSNIVHHIYCD	OR5H15	166	A6NDH6
NENETALHCAAQYGH	ANKS1B	126	Q7Z6G8
QEEASYNCHNSAITH	DCAF1	1126	Q9Y4B6
ADAQNITISQYACHD	IL17RD	76	Q8NFM7
SNGELYHEHCFVCAQ	LIMS2	31	Q7Z4I7
HHYCVNSESCTIGDD	LRP1B	4326	Q9NZR2
KIDYCASSNHGCQHE	MATN2	361	O00339
KHHCECSQGYTLNAD	MATN3	286	O15232
EFNLGCDVQHTEHVY	ENTPD7	291	Q9NQZ7
QDYHSFVTHGCTVDN	RASGRP2	176	Q7LDG7
QIIHVSEADSGNYQC	NRCAM	326	Q92823
YLQHSCHSLEAVEGQ	MTUS1	116	Q9ULD2
HYTCEALNQAGHSEK	HMCN2	2146	Q8NDA2
GCCYHLLSEEFENQH	METTL25	411	Q8N6Q8
KAIVNSCIQHYHDNC	PDCL2	146	Q8N4E4
QELDCETCQTYHFHV	FAT2	2861	Q9NYQ8
HVHNNSGCDVAYNFL	PGLYRP4	106	Q96LB8
CADVTASTYHQVQHE	NOL6	426	Q9H6R4
ETQNCHDQPHGYECS	MEGF8	2191	Q7Z7M0
YSEKATDNHVNHSSC	MPHOSPH9	896	Q99550
VCGQAHSLEENHFYS	LNX1	16	Q8TBB1
QRHFATSCHQDEYSQ	LAMB2	936	P55268
ANVLTSDNHSDYICH	L1CAM	196	P32004
AQAGTYTCHIHLQEQ	LAG3	326	P18627
EYFQCTSGHCVHSEL	LRP2	3801	P98164
SHNQISEICDLSAYH	LRGUK	201	Q96M69
QLECNHQKVVTVHYS	OVOS2	446	Q6IE36
QHSVYLLATQHCAAV	MROH1	1116	Q8NDA8
AQGCTDLHKVAHNYT	KLHL5	331	Q96PQ7
VQTSEQYEFVHHALC	PTPRR	631	Q15256
HVIFQSLSENDTHCV	PTPRU	86	Q92729
LTFCNSNIVHHIYCD	OR5H1	166	A6NKK0
RYCVSVCNQIASHLH	CEPT1	386	Q9Y6K0
TLEHNQTYECRAHNS	CSF1R	476	P07333
ATESCLSEQHDQHVY	HENMT1	236	Q5T8I9
SVCHLLNHQYEGVTE	CD1C	161	P29017
DTNTSICNQYSHIAD	DNAH3	696	Q8TD57
DFCITPQIYNESEHH	ERVK-24	446	P61566
DFCITPQIYNESEHH	ERVK-7	446	P61567
ASTIGHYDINAHACV	GLUD1	241	P00367
ACTVAVEESIAHHYN	COQ7	136	Q99807
SAAPEQSHVVQDCYH	LPA	16	P08519
QSHVVQDCYHGDGQS	LPA	21	P08519
SSDVEALHQAYCHIA	CEP162	286	Q5TB80
DFCITPQIYNESEHH	ERVK-21	556	P61565
HDSTLYCLQTDGNHL	FBXW4	336	P57775
EEGHIHKCSCSYNEQ	DNAI4	681	Q5VTH9
VIINEHCCYTVHPEN	SEC14L1	106	Q92503
VVVNEHCSYTVHPEN	SEC14L5	106	O43304
VVNHLSCDEARNHYG	SPACA9	121	Q96E40
ASTIGHYDINAHACV	GLUD2	241	P49448
ETCHSSLYEQSCEAH	CNTNAP3B	581	Q96NU0
SLYEQSCEAHKHRGN	CNTNAP3B	586	Q96NU0
ACINISHHYCNISDH	IFNGR1	76	P15260
LQDYSEHCKHNESVV	PSMD14	231	O00487
QSSNLYSCHVEHCGV	MR1	271	Q95460
SYQESLHCVQTAFHI	NOC3L	551	Q8WTT2
SVSAYAHQCCQHGVA	OTOG	1216	Q6ZRI0
NETTVHHILVYACGN	MOXD2P	236	A6NHM9
AVHCHDTYGQALANI	HMGCLL1	276	Q8TB92
NECSLHIHASYSISQ	SORT1	456	Q99523
ENHLCNAEYHTGLHT	TPSD1	191	Q9BZJ3
HHETQYCSIQAEGTS	TMEM26	86	Q6ZUK4
GHVREHDSYQVCVTD	SYNE2	2246	Q8WXH0
SAQIHCQFHASESRV	RGP1	46	Q92546
AVHCHDTYGQALANT	HMGCL	231	P35914
VDGHTICQHCYRQFS	POGZ	526	Q7Z3K3
AVQELHLSCGYTHQD	RNASEL	471	Q05823
YCHQGDCEHVIVITD	SNAPC3	311	Q92966
TNYNHHLVGASSCIE	THAP6	116	Q8TBB0
NGEYTEHLHSASCQI	TFCP2L1	201	Q9NZI6
VETAGHNIDTCYHVS	PHLDB2	1126	Q86SQ0
QTQIFHTLYHTDCNV	ASCC3	1331	Q8N3C0
QYCHTHEAVLAVIQS	CLEC2L	126	P0C7M8
QHVDSIVEFCTEQNH	CLCA1	241	A8K7I4
QYAHEHTACTNIAKL	NCAPG2	556	Q86XI2
EIHTTSNCQHFVSQV	CNKSR1	211	Q969H4
VTNHTEYHGCLQLDN	NTRK2	336	Q16620
HLEEYNTTCHLKNHT	TMEM156	151	Q8N614
YSDVEHTSVQCHALD	TM2D2	111	Q9BX73
LHFQEHSCDEQYLCQ	ZNF639	306	Q9UID6
QHQTTHTGEKSYICN	ZNF287	581	Q9HBT7
SQVCENHDNHYSEST	RALGAPA1	1531	Q6GYQ0
LHCTNGSVVYHEVLN	VWF	2786	P04275
THGQAHCSAQLYVEE	SPEG	1141	Q15772
NGEYTEHLHSASCQI	TFCP2	221	Q12800
LTESIHVCSQGENHY	TBC1D8B	216	Q0IIM8
TIHNVSQHDLGSYVC	FLT4	296	P35916
AVTNHHIVCGTYENL	TRAF7	566	Q6Q0C0
NFTECTQQHSCHYGL	SLC12A3	426	P55017
HYHENAVIQKCSTVE	SENP6	786	Q9GZR1
GQSHCECKEHYQNFV	STAB2	301	Q8WWQ8
EVHVFTNVHTDACAN	RFX7	1106	Q2KHR2
EEIVYLHCHQQVDSG	SGSM1	321	Q2NKQ1
GSCSHHYQQLLQSLE	PLEC	1096	Q15149
YCSNLNDHQRIHTGE	ZNF829	251	Q3KNS6
HYGHVDQFCSDNSVL	PLCH1	1661	Q4KWH8
AHQNIHTGEKLYECS	ZNF658	731	Q5TYW1
NHYECIALDKSNTHI	ZGRF1	746	Q86YA3
TKESAHNYENNCHEV	ZZEF1	1096	O43149
HNYENNCHEVSVFVS	ZZEF1	1101	O43149
CDQNFSDHSYLVLHQ	ZNF597	161	Q96LX8
TLCHVYHGQEAAQQR	TBXA2R	221	P21731
EQITIADNHYCSSGQ	TBC1D5	666	Q92609
AREYAVSSHHNVICQ	POTEG	341	Q6S5H5
VSSHHNVICQLLSDY	POTEG	346	Q6S5H5
HISLQEENQSSVSHC	TOPBP1	526	Q92547
ECGKSYNQRVHLTQH	ZKSCAN5	581	Q9Y2L8
QQLHSGKISHTCNEY	ZNF284	166	Q2VY69
CEENFSQSSAHIVHQ	ZNF658B	86	Q4V348
AHQNIHTGEKLYECS	ZNF658B	491	Q4V348
CLPHHEEQAYAQTQS	WNK3	1496	Q9BYP7
TTEDEVHICHNQDGY	LDLR	831	P01130
VHAHHCNDVQSELKY	NEB	4236	P20929
TTEHSGIYVCHVSNE	NECTIN4	306	Q96NY8